165 related articles for article (PubMed ID: 38515575)
1. A systematic review of primary large cell neuroendocrine carcinoma of the prostate.
Nguyen N; Franz RD; Mohammed O; Huynh R; Son CK; Khan RN; Ahmed B
Front Oncol; 2024; 14():1341794. PubMed ID: 38515575
[TBL] [Abstract][Full Text] [Related]
2. Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
Tu X; Chang T; Nie L; Qiu S; Xu H; Huang Y; Bao Y; Liu Z; Yang L; Wei Q
Urol Int; 2019; 103(4):383-390. PubMed ID: 30965328
[TBL] [Abstract][Full Text] [Related]
3. Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer.
Evans AJ; Humphrey PA; Belani J; van der Kwast TH; Srigley JR
Am J Surg Pathol; 2006 Jun; 30(6):684-93. PubMed ID: 16723845
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of neuroendocrine prostate cancer.
Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
[TBL] [Abstract][Full Text] [Related]
5. Brain metastasis from large cell neuroendocrine carcinoma of the prostate: A case report and literature review.
Aljarba SI; Murad M; Bafaquh M; Alshakweer W
Int J Surg Case Rep; 2020; 67():245-249. PubMed ID: 32070819
[TBL] [Abstract][Full Text] [Related]
6. De novo large cell neuroendocrine carcinoma of the prostate, case report and literature review.
Acosta-Gonzalez G; Qin J; Wieczorek R; Melamed J; Deng FM; Zhou M; Makarov D; Ye F; Pei Z; Pincus MR; Lee P
Am J Clin Exp Urol; 2014; 2(4):337-42. PubMed ID: 25606580
[TBL] [Abstract][Full Text] [Related]
7. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
8. De novo purely prostatic large-cell neuroendocrine carcinoma with thyroid and adrenal metastases.
Karvounis E; Zoupas I; Bantouna D; Paparodis RD; Efthymiadou R; Ioakimidou C; Panopoulos C
Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511447
[TBL] [Abstract][Full Text] [Related]
9. A rare case of large cell neuroendocrine carcinoma.
Lin D; Tan AJ; De Sousa AF; Singh-Rai R
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25331150
[TBL] [Abstract][Full Text] [Related]
10. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature.
Yang X; Chen J; Dong R
J Ovarian Res; 2019 Jul; 12(1):69. PubMed ID: 31345245
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
Wee CE; Costello BA; Orme JJ; Quevedo JF; Pagliaro LC
Prostate; 2021 Sep; 81(13):938-943. PubMed ID: 34254332
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic port-site metastasis as the manifestation of neuroendocrine prostate cancer: Case report and literature review.
Gómez González AM; Mantilla Rey D; Ortiz Zableh AM; de Valencia C; Villareal Trujillo N
Urol Case Rep; 2019 May; 24():100845. PubMed ID: 31211056
[TBL] [Abstract][Full Text] [Related]
13. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
14. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
15. Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan.
Tzou KY; Cheng WH; Lee WH; Ho CH
J Cancer Res Ther; 2018 Sep; 14(Supplement):S785-S788. PubMed ID: 30249904
[TBL] [Abstract][Full Text] [Related]
16. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
[TBL] [Abstract][Full Text] [Related]
17. Management of Large Cell Neuroendocrine Carcinoma.
Corbett V; Arnold S; Anthony L; Chauhan A
Front Oncol; 2021; 11():653162. PubMed ID: 34513663
[TBL] [Abstract][Full Text] [Related]
18. Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer.
Wang J; Xu W; Mierxiati A; Huang Y; Wei Y; Lin G; Dai B; Freedland SJ; Qin X; Zhu Y; Ye DW
Prostate; 2019 Sep; 79(13):1563-1571. PubMed ID: 31376193
[TBL] [Abstract][Full Text] [Related]
19. Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management.
Yang Z; Wang Y; Chen Y; Qian F; Zhang Y; Hu M; Zhang W; Han B
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35147672
[TBL] [Abstract][Full Text] [Related]
20. Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey.
Ustaalioglu BBO; Ulas A; Esbah O; Turan N; Bilici A; Demirci U; Alkıs N; Seker M; Oksuzoglu B; Gumus M;
Thorac Cancer; 2013 May; 4(2):161-166. PubMed ID: 28920204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
